American Money Management’s Novo Nordisk NVO Stock Holding History

American Money Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-10,300	Closed	-$282K	–	78
2015 Q2	$282K	Sell	10,300 -5,000	-33%	-$141K	0.24%	66
2015 Q1	$408K	Sell	15,300 -1,000	-6%	-$23K	0.36%	58
2014 Q4	$345K	Buy	16,300 +300	+2%	+$6.7K	0.3%	63
2014 Q3	$381K	Hold	16,000	–	–	0.32%	63
2014 Q2	$370K	Hold	16,000	–	–	0.3%	63
2014 Q1	$365K	Hold	16,000	–	–	0.31%	60
2013 Q4	$296K	Buy	+16,000	New	+$279K	0.26%	66

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

American Money Management's NVO Position: Q3 2015 in Review

American Money Management sold out of Novo Nordisk (NVO) in Q3 2015, closing a stake of 10,300 shares — an estimated $282K sold.

American Money Management first reported a position in NVO in Q4 2013 and held it in 7 quarters. The position peaked at $408K in Q1 2015. 525 funds tracked by Wall St. Rank hold NVO as of Q3 2015.

American Money Management reported no remaining Novo Nordisk position as of Q3 2015 after selling out during the quarter.
American Money Management sold 10,300 Novo Nordisk shares in Q3 2015, an estimated $282K.
American Money Management first reported a position in Novo Nordisk in Q4 2013 and held it in 7 quarters.
American Money Management's Novo Nordisk position peaked at $408K in Q1 2015.
525 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2015.

Based on American Money Management's 13F filing for Q3 2015, filed 12 Nov 2015.